Most chemistry panels report AST in units per litre (U/L), printed next to ALT, alkaline phosphatase, bilirubin and albumin. The rest of this page covers what the enzyme does inside cells, what typical and optimal ranges look like, what pushes a result up or down, and which findings are worth raising with a clinician.
The test measures how much aspartate aminotransferase is circulating in your serum at the moment of the draw. Inside a cell, AST does a specific job. It transfers an amino group from aspartate to alpha-ketoglutarate, producing oxaloacetate and glutamate. That single reaction links protein metabolism to energy production, because oxaloacetate feeds directly into the citric acid cycle. AST is also part of the malate-aspartate shuttle, the system that moves reducing equivalents into mitochondria so they can be used to make ATP. The enzyme needs vitamin B6, in its active form pyridoxal 5-phosphate, to work at all.
Two versions of the enzyme exist in human tissue, one in the cell fluid (cytosolic) and one inside mitochondria. Mild, reversible cell stress tends to release the cytosolic form. Deeper injury, where the cell membrane and the mitochondria are both disrupted, releases the mitochondrial form as well. Standard lab assays measure total AST activity rather than splitting the two, but the biology explains why larger elevations usually signal more substantial cell turnover.
AST is not a liver-only enzyme. It is concentrated in liver cells, but also in skeletal muscle, cardiac muscle, kidney, brain tissue and red blood cells. That wide distribution is the single most important thing to understand about the marker. A blood level reflects the balance between how fast the enzyme is being released from tissue and how fast it is cleared from circulation. AST clears faster than ALT, which is why AST often falls first after a one-off insult such as an unusually heavy training week.
Related: AST/ALT Ratio Calculator (De Ritis Ratio) Explained
SGOT is simply the older name for the same analyte, so SGOT and AST on a lab report mean the same test on the same tube of blood. SGOT stands for serum glutamic-oxaloacetic transaminase, a label built from the substrates involved in the reaction. Its partner enzyme, ALT, was previously called SGPT, serum glutamic-pyruvic transaminase.
Laboratories moved to AST and ALT to match standardised enzyme nomenclature, which names enzymes for what they do rather than for the chemicals in the reaction mixture. Older reports, some international labs and plenty of patient-facing software still print SGOT (AST) together, which is why people search for both names and sometimes assume they are looking at two different tests.
Units can also differ in appearance. You will see U/L on most reports and IU/L on others. Both describe enzyme activity, the amount of reaction the enzyme can catalyse under defined conditions, rather than a mass of protein. Because activity assays depend on method and temperature, results are interpreted against the issuing laboratory's own reference interval rather than a universal number.
It matters because the liver is quiet. Fat accumulation and low-grade inflammation in liver tissue can progress for years without pain, fatigue or any outward sign, and enzyme markers are among the earliest routinely measured signals that something has changed. AST is rarely dramatic in these situations. It drifts.
That makes it a useful metabolic marker rather than only a disease marker. Liver fat tracks closely with insulin resistance, visceral fat and triglyceride handling, so transaminase values are often read as part of a metabolic picture rather than in isolation. Research using AST and ALT based indices, including the AST to platelet ratio index, has reported associations between these liver-derived measures and dysglycemia in large population datasets[1]. Associations like these describe patterns across groups of people. They do not tell any individual what is happening inside their own liver, which is why imaging, history and the rest of the panel matter.
AST has two other everyday uses. It is a safety monitor, used when someone is taking a medication known to affect liver enzymes, and it is a baseline. Knowing that your AST has sat in the high teens for three years makes a reading in the mid thirties meaningful in a way that a single first-ever result never can be. Trends carry more information than snapshots, and that is true for almost every biomarker on a chemistry panel.
A typical laboratory reference range for AST in adults is roughly 10 to 40 U/L, and the range used for optimization targets is narrower. The table below sets both side by side.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| AST (SGOT) | 10 to 40 U/L | 10 to 25 U/L |
| ALT | Commonly around 7 to 56 U/L | Not listed here |
Reference ranges vary by lab, age and sex, and the exact numbers printed on your report take precedence over any range quoted online. Men often carry slightly higher transaminase values than women, partly because of greater muscle mass. Some laboratories have adopted tighter upper limits than they used a generation ago, reflecting ongoing debate about how much of the old "normal" population actually had unrecognised liver fat.
The optimal range shown above is an optimization target, not a diagnostic cut-off. It describes where a value tends to sit in people with a favourable metabolic profile, and it exists to prompt earlier conversations rather than to label anyone. A result of 32 U/L is inside the standard reference range and outside the optimal range at the same time. That is not a contradiction. It simply means the value is unremarkable by disease-detection standards and worth watching by optimization standards.
A reference range is a statistical description of a reference population, not a line between health and illness. Two people with identical AST values can have very different situations depending on muscle mass, medication, alcohol intake, training history and what every other marker on the panel is doing.
An AST above the reference range means more of the enzyme than expected has entered circulation from somewhere, and the next question is always which tissue and why. Common contributors include the following.
Liver-related possibilities include fat accumulation in liver cells, alcohol intake, viral hepatitis, medication effects, autoimmune conditions and inherited disorders of iron or copper handling. Most of these produce modest, persistent elevations rather than dramatic ones.
Muscle-related possibilities include recent intense or unfamiliar exercise, particularly eccentric or heavy resistance work, muscle injury, prolonged immobility followed by heavy activity, and rarely muscle breakdown severe enough to need urgent care. Because skeletal muscle is rich in AST, this is one of the most frequent reasons an otherwise healthy person sees an unexpected number.
Other contributors include red blood cell breakdown, either inside the body or inside a poorly handled sample tube, cardiac events, thyroid dysfunction, coeliac disease and strenuous illness of almost any kind.
The practical reading is observation, then possible meaning, then next step. The observation is that AST is above the range. The possible meaning depends entirely on context, including ALT, GGT, bilirubin, creatine kinase, symptoms, alcohol intake and recent training. The next step is to discuss the result with a clinician, who can decide whether to repeat the test after a quiet week, add markers, order imaging, or review your medication list. No single value should ever be read as a diagnosis, and an out-of-range result should never be ignored on the assumption that it is just the gym.
Comparing the two enzymes is often more informative than either alone, because ALT is far more liver-specific while AST is spread across many tissues. The ratio of AST to ALT, sometimes called the De Ritis ratio, is a long-standing clinical shorthand. Our guide to what SGPT means in a blood test covers the ALT side of that comparison in the same depth.
When ALT is higher than AST, the pattern is commonly seen in metabolic or fatty liver changes, and it is the usual shape of a mildly abnormal panel in someone with insulin resistance. When AST is clearly higher than ALT, the pattern is associated with alcohol-related liver injury and, separately, with muscle as the source of the enzyme, since muscle contributes relatively more AST than ALT. A ratio that has shifted over time is sometimes used as a signal of more advanced liver fibrosis, because ALT production can fall as liver tissue changes.
These patterns are associations, not rules. Plenty of people with alcohol-related liver change have a ratio below the classic threshold, and plenty of heavy lifters have an AST-dominant pattern with entirely unremarkable livers. The ratio is a prompt for a better question rather than an answer in itself.
Composite scores take this further by combining transaminases with other routine results. The AST to platelet ratio index is one example, and population research has examined such indices alongside measures of glucose handling[1]. Scores of this kind are screening tools used by clinicians within a wider assessment. They are not something to calculate at home and act on, and they do not replace imaging or specialist evaluation where that is warranted.
A low AST is usually unremarkable, and it is interpreted far less often than a high one. Because the test measures enzyme activity released from tissue, a low value generally means little enzyme is leaking, which is not a problem in itself.
There are a few contexts where a persistently low value is worth noting. Vitamin B6 deficiency can lower measured transaminase activity, because the assay depends on the B6-derived cofactor being available. Low muscle mass reduces the size of one of the body's main AST reservoirs, so very low values sometimes accompany frailty, prolonged illness, significant weight loss or ageing with sarcopenia. Pregnancy and dilutional states can also shift values downward.
The practical approach is the same as for any result. Look at whether the value has changed from your own previous results, look at what else on the panel has moved, including albumin and other protein markers, and raise a persistent pattern with a clinician rather than treating a single low number as meaningful. In an optimization context, a low AST alongside falling albumin, falling creatinine and reduced grip strength tells a different story than a low AST in a well-trained person who simply has quiet liver cells.
Exercise can move AST substantially, and this is one of the most common reasons a healthy person is sent for repeat liver testing. Skeletal muscle contains large amounts of the enzyme, and sessions that produce muscle damage release it into the bloodstream for days afterwards.
The usual culprits are unfamiliar training, high-volume eccentric work such as heavy lowering, long endurance efforts, and returning to training after a break. The pattern typically shows AST rising more than ALT, often with creatine kinase rising sharply at the same time. Creatine kinase is the marker that usually settles the question, because it is far more muscle-specific. If AST is up, ALT is near baseline and creatine kinase is markedly elevated after a hard week, muscle is the obvious candidate. A clinician can confirm by repeating the panel after several days of light activity.
AST is not liver-specific, because skeletal muscle contains it too, so hard training can push it up. In one study of healthy men, unaccustomed weightlifting raised AST and ALT to levels that would look abnormal on a liver panel for days after the session[2]. The same muscle source explains why AST tends to rise alongside creatine kinase when muscle breaks down, including in statin-associated muscle injury[3]. That is why a raised AST after heavy exercise is usually retested after several days of rest, often with creatine kinase, before anyone reads it as a liver problem.
The practical takeaway is simpler. If you want a clean read on liver-related AST, keep training consistent and avoid an unusually hard or novel session in the days before a draw, and tell whoever reviews your results what your training looked like that week.
Many everyday substances can raise transaminases, which is why a medication and supplement history is part of interpreting any abnormal result. Alcohol is the most familiar, and the effect is dose-related and often shows up alongside a raised GGT and an AST-dominant pattern.
Paracetamol (acetaminophen) is a particular case, since overdose causes severe liver injury, and anabolic steroid use is associated with marked enzyme and liver changes. None of this means a medication is harmful for you, and no one should stop or change a prescribed medicine based on a web page. A licensed provider evaluates whether a treatment is appropriate and whether monitoring or a change is warranted.
Medications matter too. Statins are the familiar example: they can cause mild, usually transient rises in aminotransferases, and reviews have concluded that clinically serious liver injury from statins is rare[4]. That is one reason liver enzymes are sometimes checked after a new prescription, and why any change is interpreted together with the prescriber.
Supplements are not automatically gentle. High-dose niacin, concentrated green tea extract, some bodybuilding and weight-loss products, and certain herbal preparations have been linked to liver enzyme elevations.[5][6] Reviews of herbal and dietary supplement induced liver injury describe these products as a growing share of drug-induced liver injury cases[5], with bodybuilding and multi-ingredient weight-loss products among those most often implicated[6]. The injury can show up as a rise led by ALT and AST or as a cholestatic pattern[7], and in clinical practice the usual first step is stopping the suspected product and rechecking the panel under a clinician's guidance[8]. Tell whoever orders your test about every supplement you take, because a label that says natural says nothing about what it does to your AST.
AST is measured from a standard venous blood sample, usually as part of a comprehensive metabolic panel or a liver panel, and the draw itself takes a couple of minutes. There is no separate procedure for the SGOT component, since it is one analyte among many run from the same tube.
Fasting is not required for AST itself. It is often requested anyway because the same draw usually includes glucose, insulin or lipids, which are affected by recent food. Follow the instructions your laboratory or clinician gives you rather than a general rule, since panel composition differs.
A few preparation details genuinely change the result. Intense or unaccustomed exercise in the days before a draw can raise AST, so keeping activity ordinary before testing produces a cleaner read. Alcohol in the days beforehand can shift both AST and GGT. Sample handling matters too, because red blood cells contain AST and a haemolysed sample, where cells rupture in the tube, can produce a falsely raised value. If your result is unexpectedly high with no symptoms and nothing else on the panel has moved, a repeat draw is a reasonable first step for a clinician to suggest.
Consistency helps more than perfection. Testing at a similar time of day, in a similar state of hydration, with a similar training week behind you, makes year-on-year comparison far more informative.
AST is close to uninterpretable alone, so it belongs on a panel. The core companions are the other liver-related markers plus a small set of metabolic and structural measures.
ALT is the first and most important partner, because its greater liver specificity anchors the comparison described earlier. GGT adds information about bile ducts and is sensitive to alcohol and certain medications. Alkaline phosphatase points toward bile flow and, because it also comes from bone, toward bone turnover when the liver markers are unremarkable. Bilirubin reflects how well the liver is processing the breakdown products of red blood cells. Albumin is a synthetic marker, showing what the liver is producing rather than what is leaking out of it, which is why a falling albumin alongside abnormal enzymes carries more weight than enzymes alone.
Platelet count is worth having, since it feeds composite indices and tends to fall as liver scarring advances. Creatine kinase helps separate muscle from liver as a source. Ferritin and iron studies can raise or lower suspicion of iron overload. On the metabolic side, fasting glucose, fasting insulin, HbA1c and a full lipid profile put transaminase values in context, because liver fat and insulin resistance travel together. Thyroid markers and coeliac screening are sometimes added when enzymes stay raised without explanation.
Testing several of these in a single draw is not thoroughness for its own sake. It is what makes a single enzyme value interpretable, and it is why panels, rather than individual tests, are the unit of useful information.
For a value inside the reference range with no symptoms and no new medication, annual testing alongside the rest of a chemistry panel is a reasonable rhythm, and your clinician may suggest something different based on your history. For a value that is newly out of range, retesting within a few weeks is common, since a single elevation often resolves on its own.
What a trend adds is direction. Three annual results of 18, 19 and 21 U/L describe stability. Three results of 19, 28 and 37 U/L describe a trajectory, and the trajectory is the finding even though the first two values sat comfortably inside the standard range. This is exactly where an optimal range earns its place, because it flags movement long before a report prints a flag of its own.
Timing around interventions matters too. If someone changes their alcohol intake, loses a meaningful amount of body fat, starts or stops a medication, or significantly alters training, a follow-up panel some weeks later shows whether the enzyme responded. Liver fat in particular can change over months rather than years, so repeat testing after a genuine change in habits often tells a clear story. Any schedule should be set with the clinician who knows your full history.
People often search for one AST number that means trouble, and that framing is less useful than it sounds, because context decides what a number means. A more practical approach is to treat certain combinations as reasons to seek advice without delay rather than at your next routine appointment.
Talk to a clinician promptly if a raised AST comes with yellowing of the skin or eyes, dark urine, pale stools, persistent pain under the right ribs, unexplained bruising or bleeding, swelling of the abdomen or legs, confusion, persistent vomiting, or new severe fatigue. Seek advice promptly too if AST is many times above the upper reference limit, if it has risen sharply from your own baseline, if you have recently started a new medication or supplement, if there is any possibility of paracetamol overdose, or if dark cola-coloured urine follows extreme exertion.
For a mildly raised value with no symptoms, the sensible path is still a conversation, just not an urgent one. Bring your full panel, your medication and supplement list, an honest account of alcohol intake and a description of your recent training. Those four things resolve a large share of unexplained transaminase elevations. Never ignore an out-of-range result, and never assume a benign explanation without having it checked.
Read it in three passes, observation, then possible meaning, then next step. First, write down the observation exactly as printed, the value, the units, the laboratory's own reference interval and the date. Compare it with your previous results if you have them, because your own history is the most relevant comparison you own.
Second, look for possible meaning across the panel rather than in the single line. Is ALT moving with AST or staying still. Is GGT raised, which would point attention toward alcohol, medication or bile flow. Is alkaline phosphatase or bilirubin involved. Is albumin holding steady. What were glucose, insulin and triglycerides doing. Then add the week around the draw, training, illness, alcohol, new supplements and any medication change.
Third, decide the next step with a professional. That might be repeating the panel after a quiet week, adding creatine kinase or an iron test, arranging imaging, or reviewing a prescription. Discuss your results and any treatment with a clinician or licensed provider, who can weigh them against your history and examination. This page is educational and is not medical advice.
If you want to go deeper on any single marker, FitScript publishes biomarker pages for AST and its closest partner alt, along with ggt, alkaline phosphatase and albumin, and the Metabolic + Insulin panel shows how liver enzymes sit beside glucose and insulin markers from the same draw. Within a membership built around 150+ biomarkers tested per year, Atlas, the AI health advisor, interprets those results together rather than one line at a time.
The AST blood test measures aspartate aminotransferase, an enzyme released into the bloodstream when liver, muscle, heart or red blood cells are stressed or damaged. It is run from a standard venous sample as part of a liver or metabolic panel, and it is interpreted alongside ALT rather than on its own.
AST on a blood test is an enzyme marker, reported in units per litre, that reflects how much aspartate aminotransferase has leaked from tissue into circulation. Because the enzyme exists in several tissues, a raised value points to cell turnover somewhere, and the rest of the panel helps indicate where.
It is a routine laboratory measurement of aspartate aminotransferase, historically printed as SGOT. Clinicians use it to screen for liver-related change, to monitor medications known to affect liver enzymes, and as part of a metabolic picture. A single value is an observation, never a diagnosis, and should be reviewed with a clinician.
AST stands for aspartate aminotransferase. Inside cells it helps transfer an amino group between aspartate and alpha-ketoglutarate, linking protein metabolism to energy production. In blood it acts as a leakage marker. A typical reference range is roughly 10 to 40 U/L, though exact ranges vary by laboratory, age and sex.
It means the laboratory measured aspartate aminotransferase activity in your serum. A value inside the reference range is unremarkable, while a higher value suggests more enzyme than expected has entered circulation from liver, muscle or other tissue. What it may reflect depends on ALT, GGT, symptoms, medication and recent training.
AST and ALT are the two transaminase enzymes on most chemistry panels, formerly called SGOT and SGPT. ALT is more liver-specific, while AST is also abundant in muscle, heart and red blood cells. Comparing the two, including their ratio, usually tells a clinician more than either number alone.
No single number defines that, and labelling a value is less useful than reading it in context. A clinician treats very large elevations, sharp rises from your own baseline, or any elevation with jaundice, dark urine, abdominal pain or confusion as worth discussing promptly. Never ignore an out-of-range result.
In lab results AST appears as a line item in U/L with the laboratory's own reference interval beside it, sometimes labelled SGOT. Flags indicate values outside that interval. Compare the number with your previous results and with ALT, GGT, alkaline phosphatase, bilirubin and albumin, then review it with a clinician.